Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Gains from Investment Securities (2019)

AC Immune (ACIU) reported Gains from Investment Securities of $9.2 million for Q4 2019, up 199.55% on a QoQ basis from -$9.2 million in Q3 2019.

AC Immune (ACIU) has 1 years of Gains from Investment Securities data on file, last reported at $9.2 million in Q4 2019.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to $9.2 million in Q4 2019, while the trailing twelve-month figure through Dec 2025 was -$41493.3 (changed N/A YoY) and the FY2025 annual result came in at -$18091.9, changed N/A from the prior year.
  • Gains from Investment Securities rose to $9.2 million in Q4 2019 per ACIU's latest filing, from -$9.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $9.2 million in Q4 2019 and bottomed at -$9.2 million in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 AC Immune 325.88 Mn 211.53 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 9.18 Mn
Dec 31, 2019 9.18 Mn
Sep 30, 2019 -9.22 Mn
Sep 30, 2019 -9.22 Mn
Jun 30, 2019 35,903.08
Jun 30, 2019 35,903.08
Mar 31, 2019 4.52 Mn
Mar 31, 2019 4.52 Mn